Roche touts Swiss-led R&D unit after years in Genentech's shadow
Wed, Dec 20, 2017 - 5:50 AM
Zurich
ROCHE is touting prospective new drugs from its long-underperforming Swiss-led research unit after years of leaning on its California-based Genentech arm to restock its medicine cabinet.
This year, the Swiss drugmaker - the top global spender in pharmaceutical research and...
Register to read this article. Log in if you are already a subscriber.Register to read this article. Log in if you are already a subscriber.Please log in or subscribe to continue reading.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes